Cutter & Co Brokerage’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-115,488
Closed -$149K 208
2024
Q4
$149K Hold
115,488
0.04% 191
2024
Q3
$318K Hold
115,488
0.07% 137
2024
Q2
$261K Buy
115,488
+29
+0% +$66 0.06% 160
2024
Q1
$276K Sell
115,459
-2,029
-2% -$4.85K 0.07% 152
2023
Q4
$195K Sell
117,488
-12,000
-9% -$19.9K 0.05% 179
2023
Q3
$249K Hold
129,488
0.07% 156
2023
Q2
$186K Hold
129,488
0.06% 192
2023
Q1
$272K Hold
129,488
0.08% 163
2022
Q4
$146K Sell
129,488
-40,090
-24% -$45.3K 0.05% 195
2022
Q3
$276K Hold
169,578
0.1% 153
2022
Q2
$222K Hold
169,578
0.08% 193
2022
Q1
$273K Sell
169,578
-13,879
-8% -$22.3K 0.08% 176
2021
Q4
$380K Sell
183,457
-1,285
-0.7% -$2.66K 0.1% 160
2021
Q3
$717K Hold
184,742
0.17% 120
2021
Q2
$591K Hold
184,742
0.14% 141
2021
Q1
$401K Hold
184,742
0.1% 169
2020
Q4
$414K Hold
184,742
0.11% 155
2020
Q3
$493K Hold
184,742
0.15% 129
2020
Q2
$565K Buy
+184,742
New +$565K 0.18% 113
2020
Q1
Sell
-89,240
Closed -$255K 260
2019
Q4
$255K Hold
89,240
0.09% 198
2019
Q3
$328K Hold
89,240
0.11% 188
2019
Q2
$370K Buy
89,240
+32,440
+57% +$135K 0.12% 191
2019
Q1
$290K Sell
56,800
-1,000
-2% -$5.11K 0.08% 214
2018
Q4
$198K Buy
57,800
+1,300
+2% +$4.45K 0.08% 228
2018
Q3
$340K Buy
56,500
+2,500
+5% +$15K 0.12% 168
2018
Q2
$343K Buy
54,000
+400
+0.7% +$2.54K 0.13% 158
2018
Q1
$254K Buy
53,600
+10,500
+24% +$49.8K 0.1% 190
2017
Q4
$144K Sell
43,100
-11,500
-21% -$38.4K 0.06% 227
2017
Q3
$117K Sell
54,600
-2,000
-4% -$4.29K 0.05% 244
2017
Q2
$139K Hold
56,600
0.05% 251
2017
Q1
$130K Buy
56,600
+20,600
+57% +$47.3K 0.05% 236
2016
Q4
$35K Sell
36,000
-3,500
-9% -$3.4K 0.01% 245
2016
Q3
$45K Sell
39,500
-4,000
-9% -$4.56K 0.02% 237
2016
Q2
$64K Buy
43,500
+12,000
+38% +$17.7K 0.03% 228
2016
Q1
$45K Hold
31,500
0.02% 231
2015
Q4
$52K Sell
31,500
-4,500
-13% -$7.43K 0.02% 211
2015
Q3
$84K Hold
36,000
0.04% 201
2015
Q2
$98K Buy
+36,000
New +$98K 0.04% 234